Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 114 (4) , 261-266
Abstract
Obstructive sleep apnoea syndrome (OSAS) represents a highly prevalent disease and is recognized as a risk factor for the development of various cardiovascular disorders. The pathogenesis of cardiovascular complications in OSAS is not completely understood, but the unique form of hypoxia with repetitive short cycles of desaturation followed by rapid reoxygenation termed intermittent hypoxia (IH) is likely to play a significant role. There is increasing evidence that IH leads to a preferential activation of inflammatory over adaptive pathways. This promotes activation of various inflammatory cells, particularly lymphocytes and monocytes, with the downstream consequence of expression of pro-inflammatory cytokines, chemokines and adhesion molecules that may contribute to endothelial dysfunction. This review provides a critical analysis of the current evidence of inflammatory mechanisms initiated by IH that may contribute to the cardiovascular pathogenesis in OSAS.Keywords
This publication has 59 references indexed in Scilit:
- Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesityThorax, 2007
- A critical role for p38 map kinase in NF-κB signaling during intermittent hypoxia/reoxygenationBiochemical and Biophysical Research Communications, 2007
- Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivoBiochemical and Biophysical Research Communications, 2006
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Series of Monographs on Venous Thromboembolic DiseaseCirculation, 2004
- O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1Journal of Applied Physiology, 2004
- Cardiovascular risk factors in patients with obstructive sleep apnoea syndromeEuropean Respiratory Journal, 2000
- Activation of c-Jun N-Terminal Kinases and p38-Mitogen-activated Protein Kinases in Human Heart Failure Secondary to Ischaemic Heart DiseaseJournal of Molecular and Cellular Cardiology, 1999
- REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARESThe Lancet, 1981